Citations

Clear

192 citation(s) found for "Razonable, Raymund R".

Utilization of Quantiferon-Cytomegalovirus Assay to Assess the Risk of CMV Disease and Guide Duration of Antiviral Prophylaxis in CMV-Mismatched Solid Organ Transplant Recipients
Dioverti, M. Veronica , Melendez, Dante P. , Misner, Lori, Beito, Elain, Theel, Elitza S. , Beito, E. M., Razonable, Raymund R. , Dioverti, Maria Veronica

Mayo Clinic

Open Forum Infectious Diseases | February 2, 2017 | Volume: 3 | Issue: suppl_1 | Pages: No page available

10.1093/ofid/ofw172.1841 Get It

Survey of Infection Prevention and Control (IPAC) Practices among Heart and Lung Transplant Centers
Keating, Michael R., Beam, Elena , Razonable, Raymund R.

Mayo Clinic

Open Forum Infectious Diseases | February 2, 2017 | Volume: 3 | Issue: suppl_1 | Pages: No page available

10.1093/ofid/ofw172.1867 Get It

Cytomegalovirus DNA in Transplant Recipients: Comparison of Whole Blood and Plasma Viral Loads
Dioverti, M. Veronica , Lahr, Brian D. , Germer, Jeffrey J., Yao, Joseph D. , Razonable, Raymund R. , Dioverti, Maria Veronica

Mayo Clinic

Open Forum Infectious Diseases | February 1, 2017 | Volume: 3 | Issue: suppl_1 | Pages: No page available

10.1093/ofid/ofw172.1839 Get It

Survey of Infection Prevention and Control (IPAC) Practices among Kidney and Liver Transplant Centers
Keating, Michael R., Beam, Elena , Razonable, Raymund R.

Mayo Clinic

Open Forum Infectious Diseases | February 1, 2017 | Volume: 3 | Issue: suppl_1 | Pages: No page available

10.1093/ofid/ofw172.1866 Get It

1174Comparing the Duration of Treatment for Cytomegalovirus Infection Pre and Post Quantitative Nucleic Acid Test Standardization: Does Use of a More Sensitive Assay Lead to Longer Treatment Duration?
Dioverti, M. Veronica , Razonable, Raymund R.

Mayo Clinic

Open Forum Infectious Diseases | February 1, 2017 | Volume: 1 | Issue: suppl_1 | Pages: S350-S350

10.1093/ofid/ofu052.882 Get It

Cytomegalovirus (CMV) Deoxyribonucleic Acid (DNA) Quantification in Bronchoalveolar Lavage Fluid Collected From Immunocompromised Patients With CMV Pneumonia
Germer, Jeffrey J., Lahr, Brian D. , Binnicker, M. J., Yao, Joseph D. , Beam, Elena , Limper, Andrew H. , Razonable, Raymund R.

Mayo Clinic

Open Forum Infectious Diseases | February 1, 2017 | Volume: 3 | Issue: suppl_1 | Pages: No page available

10.1093/ofid/ofw194.18 Get It

604Risk Factors for Cytomegalovirus (CMV) Reactivation in CMV-seropositive Liver Transplant Patients
Bruminhent, Jackrapong , Thongprayoon, Charat , Razonable, Raymund R.

Mayo Clinic

Open Forum Infectious Diseases | February 1, 2017 | Volume: 1 | Issue: suppl_1 | Pages: S27-S27

10.1093/ofid/ofu051.71 Get It

Epidemiology and Risk Factors for Infection after Living Donor Liver Transplantation (LDLT)
Abad, Cybéle Lara R. , Lahr, Brian D. , Razonable, Raymund R.

Mayo Clinic

Open Forum Infectious Diseases | February 1, 2017 | Volume: 3 | Issue: suppl_1 | Pages: No page available

10.1093/ofid/ofw172.1855 Get It

Treatment of alpha and beta herpesvirus infections in solid organ transplant recipients
Abad, Cybéle Lara R. , Razonable, Raymund R.

Mayo Clinic

Expert Review of Anti-infective Therapy | December 2, 2016 | Volume: 15 | Issue: 2 | Pages: 93-110

10.1080/14787210.2017.1266253 | PMID 27911112 Get It

Cytomegalovirus
Dioverti, M. Veronica , Razonable, Raymund R. , Dioverti, Maria Veronica

Mayo Clinic

Microbiology Spectrum | October 11, 2016 | Volume: 4 | Issue: 4 | Pages: No page available

10.1128/microbiolspec.dmih2-0022-2015 | PMID 27726793 Get It

ABSTRACT Cytomegalovirus (CMV), the largest of the herpesviruses, causes a wide range of clinical syndromes, from asymptomatic infection to severe disease in immunocompromised hosts. Laboratory methods for diagnosis include molecular testing, antigenemia, culture, serology, and histopathology. Treatment of CMV infection and disease is indicated in selected immunocompromised hosts, and preventive approaches are indicated in high-risk groups. This chapter reviews the epidemiology, clinical aspects, and the laboratory diagnosis and management of CMV in immunocompromised hosts.